Full Text View
Tabular View
No Study Results Posted
Related Studies
Tibolone Endometrium Study (Study 32972)(COMPLETED) (THEBES)
This study has been completed.
Study NCT00745108   Information provided by Schering-Plough

First Received on September 2, 2008.   Last Updated on October 2, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Postmenopausal Women
Interventions listed in this trial
tibolone
Tibolone 2.5 mg
CE/MPA
Additional drug interventions recognized in this trial
Medroxyprogesterone
Medroxyprogesterone Acetate
More general drug interventions related to this trial
Anabolic Agents
Androgen Antagonists
Antihypertensive Agents
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Cardiovascular Agents
Contraceptive Agents
Contraceptive Agents, Female
Contraceptive Agents, Male
Contraceptives, Oral
Contraceptives, Oral, Synthetic
Estrogen Receptor Modulators
Hormone Antagonists
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Pharmacologic Actions
Physiological Effects of Drugs
Reproductive Control Agents
Therapeutic Uses
Sponsors listed in this trial
Schering-Plough


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services